• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population.

作者信息

Hooijberg Femke, Boekel Laura, Vogelzang Erik H, Leeuw Maureen, Boers Maarten, van Vollenhoven Ronald, Lems Willem F, Nurmohamed Mike T, Wolbink Gertjan

机构信息

Amsterdam Rheumatology and Immunology Center, Location Reade, Department of Rheumatology, 1056 AB Amsterdam, Netherlands.

Department of Medical Microbiology, Amsterdam University Medical Center, Vanderbilt University Medical Center, Amsterdam, Netherlands.

出版信息

Lancet Rheumatol. 2020 Oct;2(10):e583-e585. doi: 10.1016/S2665-9913(20)30286-1. Epub 2020 Aug 27.

DOI:10.1016/S2665-9913(20)30286-1
PMID:33106791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7579459/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6631/7579459/5b7c14545bf5/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6631/7579459/5b7c14545bf5/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6631/7579459/5b7c14545bf5/fx1.jpg

相似文献

1
Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population.患有风湿性疾病的患者比普通人群更严格地遵守新冠疫情隔离措施。
Lancet Rheumatol. 2020 Oct;2(10):e583-e585. doi: 10.1016/S2665-9913(20)30286-1. Epub 2020 Aug 27.
2
A Simple Bayesian Method for Evaluating Whether Data From Patients With Rheumatic Diseases Who Have Been Under Chronic Hydroxychloroquine Medication Since Before the COVID-19 Outbreak Can Speak to Hydroxychloroquine's Prophylactic Effect Against Infection With SARS-CoV-2.一种简单的贝叶斯方法，用于评估自新冠疫情爆发前就一直在接受慢性羟氯喹治疗的风湿病患者的数据，是否能说明羟氯喹对感染新冠病毒的预防作用。
Front Med (Lausanne). 2020 Aug 13;7:490. doi: 10.3389/fmed.2020.00490. eCollection 2020.
3
Impact of Chronic Use of Antimalarials on SARS-CoV-2 Infection in Patients With Immune-Mediated Rheumatic Diseases: Protocol for a Multicentric Observational Cohort Study.长期使用抗疟药对免疫介导的风湿性疾病患者感染严重急性呼吸综合征冠状病毒2的影响：一项多中心观察性队列研究方案
JMIR Res Protoc. 2020 Oct 14;9(10):e23532. doi: 10.2196/23532.
4
[Cardiovascular risk in patients with rheumatic disease and its management].[风湿性疾病患者的心血管风险及其管理]
Vnitr Lek. 2018 Winter;64(1):51-59.
5
Challenges and countermeasures of thoracic oncology in the epidemic of COVID-19.新型冠状病毒肺炎疫情下胸部肿瘤学面临的挑战与对策
Transl Lung Cancer Res. 2020 Apr;9(2):337-347. doi: 10.21037/tlcr.2020.02.10.
6
Increased cardiovascular risk factors in different rheumatic diseases compared with the general population.与普通人群相比，不同风湿性疾病存在心血管危险因素增加的情况。
Rheumatology (Oxford). 2013 Jan;52(1):210-6. doi: 10.1093/rheumatology/kes194. Epub 2012 Jul 30.
7
Rheumatic diseases: a general practitioner's view.风湿性疾病：全科医生的观点。
Baillieres Clin Rheumatol. 1987 Dec;1(3):601-22. doi: 10.1016/s0950-3579(87)80047-x.
8
Advice on Standardized Diagnosis and Treatment for Spinal Diseases during the Coronavirus Disease 2019 Pandemic.2019年冠状病毒病大流行期间脊柱疾病标准化诊断与治疗建议。
Asian Spine J. 2020 Apr;14(2):258-263. doi: 10.31616/asj.2020.0122. Epub 2020 Mar 30.

引用本文的文献

1
The effects on clinical characteristics, potential factors and outcomes in SAPHO patients during the COVID-19 epidemic.新型冠状病毒肺炎疫情期间对滑膜炎、痤疮、脓疱病、骨肥厚、骨炎（SAPHO）患者临床特征、潜在因素及预后的影响。
Front Med (Lausanne). 2025 Jul 16;12:1580989. doi: 10.3389/fmed.2025.1580989. eCollection 2025.
2
Effect of the COVID-19 pandemic on clinical characteristics and outcomes of adult pneumococcal meningitis patients - a Dutch prospective nationwide cohort study.COVID-19 大流行对成人肺炎球菌性脑膜炎患者的临床特征和结局的影响 - 一项荷兰前瞻性全国队列研究。
Infection. 2024 Oct;52(5):1657-1662. doi: 10.1007/s15010-024-02305-x. Epub 2024 Jun 3.
3

本文引用的文献

1
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case-control study.意大利北部风湿性疾病患者中的新型冠状病毒肺炎：一项单中心观察性病例对照研究。
Lancet Rheumatol. 2020 Sep;2(9):e549-e556. doi: 10.1016/S2665-9913(20)30169-7. Epub 2020 Jun 18.
2
The association between severe or dead COVID-19 and autoimmune diseases: A systematic review and meta-analysis.重症或死亡的新型冠状病毒肺炎与自身免疫性疾病之间的关联：一项系统评价和荟萃分析。
J Infect. 2020 Sep;81(3):e93-e95. doi: 10.1016/j.jinf.2020.05.065. Epub 2020 Jun 2.
3
Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: A population-based study in the first two months of COVID-19 outbreak in Italy.
Work participation and the COVID-19 pandemic: an observational study in people with inflammatory rheumatic diseases and population controls.
工作参与度与新冠疫情：一项针对炎症性风湿疾病患者及人群对照的观察性研究
Rheumatol Adv Pract. 2024 Mar 9;8(2):rkae026. doi: 10.1093/rap/rkae026. eCollection 2024.
4
Efficacy and Safety of Anti-SARS-CoV-2 Antiviral Agents and Monoclonal Antibodies in Patients with SLE: A Case-Control Study.SLE 患者抗 SARS-CoV-2 抗病毒药物和单克隆抗体的疗效和安全性：一项病例对照研究。
Biomolecules. 2023 Aug 22;13(9):1273. doi: 10.3390/biom13091273.
5
Exploring the longer-term impact of the COVID-19 pandemic on physical and mental health of people with inflammatory rheumatic diseases: a cross-sectional survey.探讨 COVID-19 大流行对炎症性风湿病患者身心健康的长期影响：一项横断面调查。
Clin Rheumatol. 2023 Jul;42(7):1903-1909. doi: 10.1007/s10067-023-06565-0. Epub 2023 Mar 7.
6
A multidisciplinary lifestyle program for rheumatoid arthritis: the 'Plants for Joints' randomized controlled trial.类风湿关节炎的多学科生活方式方案：“关节植物”随机对照试验。
Rheumatology (Oxford). 2023 Aug 1;62(8):2683-2691. doi: 10.1093/rheumatology/keac693.
7
Consideration of health literacy in patient information: a mixed-methods study of COVID-19 crisis communication in Dutch rheumatology.患者信息中的健康素养考量：一项关于荷兰风湿病学领域 COVID-19 危机沟通的混合方法研究。
BMC Rheumatol. 2022 Sep 7;6(1):52. doi: 10.1186/s41927-022-00283-x.
8
SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period.在奥密克戎毒株占主导期间免疫介导性炎症疾病患者中的新型冠状病毒2型突破性感染
Lancet Rheumatol. 2022 Nov;4(11):e747-e750. doi: 10.1016/S2665-9913(22)00221-1. Epub 2022 Aug 23.
9
Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022.2022年类风湿关节炎患者的心血管疾病风险
J Clin Med. 2022 May 11;11(10):2704. doi: 10.3390/jcm11102704.
10
[Not Available].[无可用内容]
Rev Rhum Ed Fr. 2022 Jun;89(4):405-411. doi: 10.1016/j.rhum.2022.04.010. Epub 2022 May 2.
COVID-19 在接受生物制剂或小分子治疗的慢性炎症性风湿病患者中的流行情况：意大利 COVID-19 疫情爆发头两个月的基于人群的研究。
Joint Bone Spine. 2020 Oct;87(5):439-443. doi: 10.1016/j.jbspin.2020.05.003. Epub 2020 May 20.
4
Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.COVID-19 在接受靶向生物制剂和合成疾病修饰抗风湿药物治疗的成人和儿科风湿性疾病患者队列中的发病率。
Semin Arthritis Rheum. 2020 Aug;50(4):564-570. doi: 10.1016/j.semarthrit.2020.05.001. Epub 2020 May 16.
5
What is the true incidence of COVID-19 in patients with rheumatic diseases?风湿性疾病患者中新型冠状病毒肺炎的真实发病率是多少？
Ann Rheum Dis. 2021 Feb;80(2):e18. doi: 10.1136/annrheumdis-2020-217615. Epub 2020 Apr 22.